U.S. Pharmaceuticals & Biotech High Growth Potential Companies

Anika Therapeutics

Market Cap: US$194.5m

A joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally.

Catalyst Pharmaceuticals

Market Cap: US$2.8b

A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.

MariMed

Market Cap: US$32.1m

Engages in cultivation, production, and selling of branded cannabis products in the United States and internationally.

Supernus Pharmaceuticals

Market Cap: US$1.8b

A biopharmaceutical company, develops and commercializes products for the treatment of central nervous system (CNS) diseases in the United States.

Azenta

Market Cap: US$1.2b

Provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.

Aytu BioPharma

Market Cap: US$6.4m

A pharmaceutical company, focuses on commercializing novel therapeutics drugs in the United States and internationally.

ANI Pharmaceuticals

Market Cap: US$1.4b

A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.

IQVIA Holdings

Market Cap: US$26.3b

Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

Oculis Holding

Market Cap: US$949.3m

A clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic diseases in Switzerland, Iceland, and internationally.

Bio-Rad Laboratories

Market Cap: US$6.8b

Manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America.

Revvity

Market Cap: US$11.5b

Provides health sciences solutions, technologies, and services worldwide.

Minerva Neurosciences

Market Cap: US$10.3m

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases.

Novavax

Market Cap: US$1.0b

A biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally.

Creative Medical Technology Holdings

Market Cap: US$3.6m

A commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States.

BioMarin Pharmaceutical

Market Cap: US$11.5b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Amgen

Market Cap: US$158.8b

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

Genenta Science

Market Cap: US$70.0m

A clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy.

Charles River Laboratories International

Market Cap: US$5.2b

Charles River Laboratories International, Inc.

Immunic

Market Cap: US$94.7m

A biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany.

Perrigo

Market Cap: US$3.4b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.